• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

Author page: Montse

HomeBlogAuthor page: Montse

Thermo-Responsive Hydrogels for Cancer Local Therapy: Challenges and State-of-Art.

28 July, 2021 1288

Rafael D, Merce Roca Melendres, Andrade F, Montero S, Martinez-Trucharte F, Vilar-Hernandez M, Francisco Duran-Lara, Schwartz S Jr, Abasolo I Int J Pharm. 2021 Jul 28:120954. doi: 10.1016/j.ijpharm.2021.120954...

Read more

Pluronic F127-micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer

23 June, 2021 823

Marwa M Abu-Serie, Fernanda Andrade, Patrícia Camára-Sánchez, Joaquin Seras-Franzoso, Diana Rafael, Zamira V Diaz-Riascos, Petra Gener, Ibane Abasolo, Simó Schwartz Jr. Nanomedicine (Lond.) (Epub ahead of print)...

Read more

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice

13 May, 2021 673

Sandra Claveau , Marek Kindermann , Alexandre Papine , Zamira V Díaz-Riascos,  Xavier Délen, Patrick Georges , Roser López-Alemany , Òscar Martínez Tirado , Jean-Rémi Bertrand , Ibane Abasolo , Petr Cigler , François Treussart Nanoscale.  2021...

Read more

Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method

20 March, 2021 942

  Josep Merlo-Mas, Judit Tomsen Melero, Jose Luis Corchero, Elisabet González Mira, Albert Font, Jannik N.Pedersen, Natalia Garcia Aranda, Edgar Cristóbal-Lecina, Marta Alcaina-Hernando,  Rosa Mendoza, Elena García Fruitós, Teresa...

Read more

Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders

12 March, 2021 761

Seras-Franzoso J, Diaz-Riascos ZV, Corchero JL, Gonzalez P, Garcia-Aranda N, Mandana M, Riera R, Boullosa A, Mancilla S, Grayston A, Molto-Abad M, Garcia-Fruitos E, Mendoza R, Pintos-Morell G, Albertazzi L, Rosell A, Casas J, Villaverde A...

Read more

Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways

10 March, 2021 775

Eva Espinosa-Cano, Miguel Huerta-Madroñala, Patricia Cámara-Sánchez, Joaquin Seras-Franzoso, Simo Schwartz, Ibane Abasolo, Julio San Román, Maria Rosa Aguilar Materials Science & Engineering C.  Available online 10 March 2021, 112024  ...

Read more

Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field

9 March, 2021 740

Andrade F, Roca-Melendres MM, Duran-Lara EF, Rafael D, Schwartz S Jr Cancers (Basel). 2021 Mar 9;13(5). pii: cancers13051164. doi: 10.3390/cancers13051164. https://pubmed.ncbi.nlm.nih.gov/33803133/ Abstract Cancer remains as the second leading...

Read more

Impact of Chemical Composition on the Nanostructure and Biological Activity of alpha-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment.

24 February, 2021 656

Tomsen-Melero J, Passemard S, Garcia-Aranda N, Diaz-Riascos ZV, Gonzalez-Rioja R, Nedergaard Pedersen , Lyngso J, Merlo-Mas J, Cristobal-Lecina E, Corchero JL, Pulido D, Camara-Sanchez P, Portnaya I, Ionita I, Schwartz S Jr, Veciana J, Sala S...

Read more

Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.

19 January, 2021 660

Andrade F, Rafael D, Vilar-Hernandez M, Montero S, Martinez-Trucharte F, Seras-Franzoso J, Diaz-Riascos ZV, Boullosa A, Garcia-Aranda N, Camara-Sanchez P, Arango D, Nestor M, Abasolo I, Sarmento B, Schwartz S Jr J Control Release. 2021 Jan 19...

Read more

Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease

13 December, 2020 1380

Abasolo I, Seras-Franzoso J, Molto-Abad M, Diaz-Riascos V, Corchero JL, Pintos-Morell G, Schwartz S Jr Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Dec 13:e1684. doi: 10.1002/wnan.1684. Abstract Lysosomal storage disorders (LSDs) are a...

Read more

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics

5 December, 2020 654

Anna Ulldemolins, Joaquin Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo, Petra Gener, Simo Schwartz Jr Cancer Drug Resist 2020;3:[Online First]  Review ...

Read more

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells

21 February, 2020 960

Montero S, Seras-Franzoso J, Andrade F, Martinez-Trucharte F, Vilar-Hernández M, Quesada M, Xandri H, Arango D, Abasolo I, Rafael D, Schwartz S Jr. Pharmaceutics. 2020 Feb 21;12(2). pii: E185. doi: 10.3390/pharmaceutics12020185...

Read more
123…11-15
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR
Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR
4 March, 2021by CIBBIM - Nanomedicine0
Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer
Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer
4 March, 2021by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More